Concepedia

Veronica Conca

VC

Statistics

Publications

21

Citations

890

H-Index

16

Active since

1995

Affiliations

University of Pisa(Current)

Azienda Ospedaliera Universitaria Pisana

Fondazione IRCCS Istituto Nazionale dei Tumori

Istituto Oncologico Veneto

Istituti di Ricovero e Cura a Carattere Scientifico

Veronica Conca is an author at University of Pisa specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1995–2024

21

Publications

21

Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial

Carlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio et al. · The Lancet Oncology · 2022 · 246 citations · Full text

, , +9

Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers

Giovanni Fucà, Romain Cohen, Sara Lonardi et al. · Journal for ImmunoTherapy of Cancer · 2022 · 107 citations · Full text

Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications

Roberto Moretto, Andrew Elliott, Jian Zhang et al. · JNCI Journal of the National Cancer Institute · 2021 · 72 citations · Full text

Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With <i>RAS/BRAF</i> Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO

Daniele Rossini, Carlotta Antoniotti, Sara Lonardi et al. · Journal of Clinical Oncology · 2022 · 71 citations · Full text

Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer

Margherita Ambrosini, Benoı̂t Rousseau, Paolo Manca et al. · Annals of Oncology · 2024 · 56 citations · Full text

1–5 of 21